Understanding managed care’s effect on the U.S. pharmaceutical marketplace isn’t only an imperative to capturing market share – it’s the key that can unlock a drug’s full potential. Higher co-pays, multi-tier formularies, cost-shifting to patients, and products moving to OTC are only a few of the managed care issues confronting pharmaceutical companies every day.
With deep domain knowledge of the IMS, Verispan, Walter Kohlers and other sources of data, ITS can add business value by,
1. Generate reports of the required products and its competitive product activities.
2. A consistent and actionable user friendly reporting system
3. Comparable reports of the products Vs different payors enabling our clients to make data driven decisions.
4. Provide user defined reports that ensures the clients to identify business growth opportunities.